Showing 1731-1740 of 1970 results for "".
- Fast Facts on Non-Surgical Cosmetic Procedures in 2019 from the Aesthetic Societyhttps://modernaesthetics.com/news/fast-facts-on-non-surgical-cosmetic-procedures-in-2019-from-the-aesthetic-society-1/2472940/And the Aesthetic Society’s 2019 numbers are in… The top 5 non-surgical procedures performed in 2019 by board-certified U.S. plastic surgeons were: Botulinum Toxin (including Botox, Dysport, Xeomin) 1,712,994 procedures Hyaluronic Acid (includin
- Aesthetic Practices Weigh Pros and Cons of COVID-19 Testing Patients and Staff as Part of Reopening Planshttps://modernaesthetics.com/news/aesthetic-practices-weigh-pros-and-cons-of-covid-19-testing-patients-and-staff-as-part-of-reopening-plans/2472938/COVID-19 antibody testing can play an important role in identifying people who have recovered from the SARS-CoV-2 virus and who have high levels of antibodies in their blood that could potentially help other critically ill COVID-19 patients. The presence of antibodies may also suggest immuni
- Aesthetic Society Names New President, Executive Boardhttps://modernaesthetics.com/news/aesthetic-society-names-new-president-executive-board-1/2472936/Herluf G. Lund, Jr., MD, FACS, a plastic surgeon practicing in St. Louis, Missouri, is the new President of The Aesthetic Society. Dr. Lund and his leadership team will focus on guiding membership through the COVID-19 crisis and completing a number of critical projects in developme
- It’s a Deal: AbbVie Completes Acquisition of Allerganhttps://modernaesthetics.com/news/its-a-deal-abbvie-completes-acquisition-of-allergan/2472932/AbbVie completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court. In connection with the closing of the transaction, the AbbVie Board of Directors has elec
- Galderma's Restylane Kysse FDA Approved for Lip Augmentation and Upper Perioral Rhytidshttps://modernaesthetics.com/news/galdermas-restylane-kysse-fda-approved-for-lip-augmentation-and-upper-perioral-rhytids/2472927/The FDA recently approved Galderma'a Restylane Kysse for lip augmentation and the correction of upper perioral rhytids in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology globally referred to as t
- ISPA Consumer Survey: Med Spas May Need a Post-COVID-19 Facelift to Ease Consumer Concernshttps://modernaesthetics.com/news/ispa-consumer-survey-medspas-may-need-a-post-covid-19-facelift-to-ease-consumer-concerns/2472923/Everyone is feeling anxious about returning to public spaces including spas following the COVID-19 pandemic, according to the new ISPA Consumer Snapshot Initiative. “We know that COVID-19 has created a lot of uncertainty in many industries, including the spa industry,” says
- COVID-19 By the Numbers: April 28 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-28-edition-1/2472920/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- Industry Responds to COVID-19: ISPA Offers New Checklist for Reopening Spas after COVID-19https://modernaesthetics.com/news/industry-responds-ispa-offers-new-checklist-for-reopening-spas-after-covid-19/2472919/The International SPA Association (ISPA) is rolling out the first components of the ISPA COVID-19 Reopening Toolkit including an expansive Spa Reopening Checklist to help guide spas through the process, communicatio
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co
- Industry Responds to COVID-19: Galderma, Timeless Skin Care, UCBhttps://modernaesthetics.com/news/industry-responds-to-covid-19-galderma-timeless-skin-care-ucb/2472915/Galderma. Galderma is offering educational webinars to support aesthetic customers during the pandemic. Galderma Italy donated Cetaphil hydrating lotion to hospitals and are also set to